LIGAND PHARM Performance

LGNXZ -- USA Stock  

USD 0.06  0.00  0.00%

The company secures Beta (Market Risk) of 0.0 which conveys that the returns on MARKET and LIGAND PHARM are completely uncorrelated. Although it is extremely important to respect LIGAND PHARM INC price patterns, it is better to be realistic regarding the information on equity historical price patterns. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By evaluating LIGAND PHARM INC technical indicators you can today evaluate if the expected return of 0.0% will be sustainable into the future. LIGAND PHARM INC now secures a risk of 0.0%. Please verify LIGAND PHARM INC Standard Deviation, Value At Risk, Kurtosis, as well as the relationship between Jensen Alpha and Semi Variance to decide if LIGAND PHARM INC will be following its current price movements.
Horizon     30 Days    Login   to change

LIGAND PHARM INC Relative Risk vs. Return Landscape

If you would invest (100.00)  in LIGAND PHARM INC on January 24, 2019 and sell it today you would earn a total of  100.00  from holding LIGAND PHARM INC or generate -100.0% return on investment over 30 days. LIGAND PHARM INC is currently producing negative expected returns and takes up 0.0% volatility of returns over 30 trading days. Put another way, 0% of traded equities are less volatile than the company and 99% of traded equity instruments are likely to generate higher returns over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 

LIGAND PHARM Market Risk Analysis

Sharpe Ratio = 0.0
Good Returns
Average Returns
Small Returns
Based on monthly moving average LIGAND PHARM is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LIGAND PHARM by adding it to a well-diversified portfolio.

LIGAND PHARM Performance Rating

LIGAND PHARM INC Risk Adjusted Performance Analysis


Risk-Adjusted Performance

Over the last 30 days LIGAND PHARM INC has generated negative risk-adjusted returns adding no value to investors with long positions.


Equity Alerts and Improvement Suggestions

LIGAND PHARM INC is not yet fully synchronised with the market data
LIGAND PHARM INC has some characteristics of a very speculative penny stock
Please see also Stocks Correlation. Please also try Headlines Timeline module to stay connected to all market stories and filter out noise. drill down to analyze hype elasticity.